Safety, Tolerability, and Pharmacokinetics of SAB-185 in Healthy Participants
Clinical trial NCT04468958 · COMPLETED
Trial details
- NCT number
- NCT04468958
- Sponsor
- SAb Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2020-12-23
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.